{
    "2021-01-22": [
        [
            {
                "time": "2021-11-09",
                "original_text": "Lilly's (LLY) Bamlanivimab Lowers COVID-19 Risk in Nursing Homes",
                "features": {
                    "keywords": [
                        "Bamlanivimab",
                        "COVID-19",
                        "Nursing Homes"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-09",
                "original_text": "Lilly Completes Acquisition of Prevail Therapeutics",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Acquisition",
                        "Prevail Therapeutics"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-09",
                "original_text": "Pharma Stock Roundup: FDA Nod to MRK, AZN, JNJ, GSK Drugs, LLY's New Antibody Deal",
                "features": {
                    "keywords": [
                        "FDA",
                        "MRK",
                        "AZN",
                        "JNJ",
                        "GSK",
                        "LLY",
                        "Antibody Deal"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-09",
                "original_text": "The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa",
                "features": {
                    "keywords": [
                        "Fluidigm",
                        "Saliva-Based",
                        "COVID",
                        "Test",
                        "Europe",
                        "China",
                        "Amarin",
                        "Vascepa"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}